Cargando…
Antibody-Drug Conjugates in Prostate Cancer: A Systematic Review
The prognosis in the setting of metastatic castration-resistant prostate cancer patients (mCRPC) remains limited. Therefore, novel treatment strategies remain an unmet need. Antibody-drug conjugates (ADC) emerged as a new drug concept with the potential to deliver a cytotoxic payload with limited of...
Autores principales: | Sardinha, Mariana, Palma dos Reis, Ana Filipa, Barreira, João Vasco, Fontes Sousa, Mário, Pacey, Simon, Luz, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983052/ https://www.ncbi.nlm.nih.gov/pubmed/36874351 http://dx.doi.org/10.7759/cureus.34490 |
Ejemplares similares
-
Full recovery of a stage IV cancer patient facing COVID-19 pandemic
por: Parmanande, Anuraj, et al.
Publicado: (2020) -
Spontaneous Rupture of a Urinary Bladder Diverticulum in Women: A Rare Cause of an Acute Abdomen
por: Cardoso, Vasco S, et al.
Publicado: (2023) -
Prolonged Response to an IGF-1 Receptor Antibody in a Patient with Metastatic Castration Prostate Cancer with Neuroendocrine Differentiation
por: Graff, Julie N, et al.
Publicado: (2015) -
Anti-CD27 Antibody Potentiates Antitumor Effect of Dendritic Cell–Based Vaccine in Prostate Cancer–Bearing Mice
por: Wei, Si-Ming, et al.
Publicado: (2015) -
Current Status of Monoclonal Antibodies-Based Therapies in Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis of Clinical Trials
por: Tarrar, Talha Azam, et al.
Publicado: (2022)